Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Amphetamine-Related Disorders | 2 | D019969 | ClinicalTrials |
| Substance-Related Disorders | 2 | D019966 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL5095323 |
CONTENTS
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Amphetamine-Related Disorders | 2 | D019969 | ClinicalTrials |
| Substance-Related Disorders | 2 | D019966 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL5095323 |